Logo image of SCNI

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) Stock Price, Quote, News and Overview

NASDAQ:SCNI - Nasdaq - US09073Q3039 - ADR - Currency: USD

2.214  -0.05 (-2.04%)

After market: 2.21 0 (-0.18%)

SCNI Quote, Performance and Key Statistics

SCINAI IMMUNOTHERAPEUTICS LT

NASDAQ:SCNI (6/20/2025, 8:00:02 PM)

After market: 2.21 0 (-0.18%)

2.214

-0.05 (-2.04%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High8.92
52 Week Low1.9
Market Cap2.07M
Shares933.70K
Float724.99K
Yearly DividendN/A
Dividend YieldN/A
PE1.04
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-07 2007-06-07


SCNI short term performance overview.The bars show the price performance of SCNI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30

SCNI long term performance overview.The bars show the price performance of SCNI in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of SCNI is 2.214 USD. In the past month the price decreased by -22.6%. In the past year, price decreased by -38.5%.

SCINAI IMMUNOTHERAPEUTICS LT / SCNI Daily stock chart

SCNI Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.04 327.31B
AMGN AMGEN INC 13.94 155.58B
GILD GILEAD SCIENCES INC 14.02 134.97B
VRTX VERTEX PHARMACEUTICALS INC N/A 113.22B
REGN REGENERON PHARMACEUTICALS 11.5 55.03B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 40.38B
ARGX ARGENX SE - ADR 94.29 33.10B
ONC BEONE MEDICINES LTD-ADR 6.32 26.73B
BNTX BIONTECH SE-ADR N/A 25.61B
NTRA NATERA INC N/A 23.47B
INSM INSMED INC N/A 18.70B
BIIB BIOGEN INC 8.03 18.62B

About SCNI

Company Profile

SCNI logo image Scinai Immunotherapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunomodulation therapies for infectious diseases. The Company’s core focus is to develop NanoAbs for the treatment of various diseases such as COVID-19, psoriasis, and asthma. The firm's product NanoAb is based on alpaca-derived nanosized antibodies (NanoAbs), also known as VHH-antibodies. Additionally, the Company offers manufacturing facilities, aseptic fill and finish suites, laboratories, and experienced professionals for other research and development companies. Scinai Immunotherapeutics Ltd operates in Israel.

Company Info

SCINAI IMMUNOTHERAPEUTICS LT

Jerusalem Biopark, 2Nd Floor, Hadassah Ein Kerem Campus

JERUSALEM IL

Employees: 31

SCNI Company Website

SCNI Investor Relations

Phone: 97289302529

SCINAI IMMUNOTHERAPEUTICS LT / SCNI FAQ

What is the stock price of SCINAI IMMUNOTHERAPEUTICS LT today?

The current stock price of SCNI is 2.214 USD. The price decreased by -2.04% in the last trading session.


What is the ticker symbol for SCINAI IMMUNOTHERAPEUTICS LT stock?

The exchange symbol of SCINAI IMMUNOTHERAPEUTICS LT is SCNI and it is listed on the Nasdaq exchange.


On which exchange is SCNI stock listed?

SCNI stock is listed on the Nasdaq exchange.


What is SCINAI IMMUNOTHERAPEUTICS LT worth?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) has a market capitalization of 2.07M USD. This makes SCNI a Nano Cap stock.


How many employees does SCINAI IMMUNOTHERAPEUTICS LT have?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) currently has 31 employees.


What are the support and resistance levels for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

SCINAI IMMUNOTHERAPEUTICS LT (SCNI) has a resistance level at 2.22. Check the full technical report for a detailed analysis of SCNI support and resistance levels.


Should I buy SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock pay dividends?

SCNI does not pay a dividend.


What is the Price/Earnings (PE) ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI)?

The PE ratio for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 1.04. This is based on the reported non-GAAP earnings per share of 2.12 and the current share price of 2.214 USD. Check the full fundamental report for a full analysis of the valuation metrics for SCNI.


What is the Short Interest ratio of SCINAI IMMUNOTHERAPEUTICS LT (SCNI) stock?

The outstanding short interest for SCINAI IMMUNOTHERAPEUTICS LT (SCNI) is 0.06% of its float. Check the ownership tab for more information on the SCNI short interest.


SCNI Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SCNI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SCNI. SCNI has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SCNI Financial Highlights

Over the last trailing twelve months SCNI reported a non-GAAP Earnings per Share(EPS) of 2.12.


Industry RankSector Rank
PM (TTM) 400.76%
ROA 19.61%
ROE 26.43%
Debt/Equity 0.03
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

SCNI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to SCNI. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners26.55%
Ins Owners8.75%
Short Float %0.06%
Short Ratio0
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A